Back to search
FDAFDA · Food and drugs·Recall number D-1571-2014

Rifampin for Injection USP, 600 mg*/vial (Sterile), supplied in sterile glass vials, Rx only For IV Infusion only, individually boxed, Mfd. for: Akorn, Inc., Lake Forest, IL --- NDC 17478-151-42

Published October 1, 2014 · Recall initiated: August 5, 2014

Summary

FDA records drug Class III recall D-1571-2014, published October 1, 2014 and initiated August 5, 2014. Recalling firm: Akorn, Inc.; Status: Terminated; Reported quantity: 5,539 vials; Lot: Lot: 12RIF4A, Expiration Date: 9/30/2014. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn, Inc.
Distributor
Nationwide
Lot
Lot: 12RIF4A, Expiration Date: 9/30/2014
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Rifampin for Injection USP, 600 mg*/vial (Sterile), supplied in sterile glass vials, Rx only For IV Infusion only, individually boxed, Mfd. for: Akorn, Inc., Lake Forest, IL --- NDC 17478-151-42 recalled?

Yes. FDA published recall D-1571-2014 on October 1, 2014. Reported hazard: Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point

What should I do if I have this product?

Voluntary: Firm initiated · Letter